Federal health officials say adults with pre-existing medical conditions who have already received a Moderna or Pfizer double vaccine and a third shot will be able to get a fourth.
“Those who are moderately and severely immunocompromised can receive a total of four doses of the COVID-19 vaccine,” the Centers for Disease Control said in its guidelines, which were updated Tuesday.
The CDC approved a third dose in August for immunocompromised people 18 years of age or older. The fourth shot should be available at least six months after the third, the CDC said. The CDC no longer considers third shots approved for modern and Pfizer vaccines as booster.
Some medical conditions and treatments can make it difficult for immunocompromised people to build and maintain immunity, which requires a fourth shot, the CDC says.
Also in the news:
► Los Angeles City Council has delayed the date when city workers must be vaccinated against COVID-19 by Dec. 18, but those whose shots have not been taken must be tested twice a week at their expense ($ 65 a pop), the Los Angeles Times reports. Has done.
More than 75% of the eligible population in Maine and about 70% of the entire population have been fully vaccinated, according to state data released Wednesday. About 58% of the entire U.S. population is fully vaccinated.
Massachusetts education officials have increased the requirement for masks in all K-12 public schools until at least Jan. 15. If school officials can show that at least 80% of all students and staff have been vaccinated, they can revoke the local order.
স্বাস্থ্য Australian Health Minister Greg Hunt has announced that double-vaccinated Australians will be allowed to travel abroad and / or return home from Monday. Many families have been separated due to the strict border closure that came into effect in March 2020.
► A Brazilian Senate committee on Tuesday recommended that President Zaire Bolsonaro face multiple criminal charges for activities related to and exclusion of the world’s second-highest COVID-19 death toll.
সংখ্যা Today’s issue: According to Johns Hopkins University, there are 45.6 million confirmed COVID-19 cases and more than 739,000 deaths recorded in the United States. Worldwide total: more than 244.8 million cases and 4.96 million deaths. According to the CDC, more than 190.8 million Americans – 57.8% of the population – have been fully vaccinated.
What we are reading: Own an iPhone? You can now keep a digital version of your COVID-19 vaccine card in your phone’s Apple Wallet.
Refresh this page for the latest news. Want more? Sign up for USA TODAY’s Coronavirus Watch newsletter to receive updates directly in your inbox and join our Facebook group.
Poll found a lack of public knowledge about the vaccine
President Joe Biden has faced a problem of ignorance in his efforts to bring the country out of the epidemic and this is affecting public confidence in his administration.
A new Axios / Ipsos poll shows that Americans are unsure about how well the COVID-19 vaccine works, despite having information about its ability to protect people from serious illness, hospitalization and death, and small amounts of infection. Lack of knowledge is probably contributing to the continued vaccine holdout of 60 million people who are eligible for shots and may lose confidence in the Biden administration.
Confidence that his government can ensure that the epidemic has dropped from 52% at the end of January to 44% in the latest survey after the economy has recovered quickly.
At the root of some of that eroded confidence may be how little Americans know about the vaccine, which is at the heart of Biden’s plan for the United States to survive the epidemic. In the poll, just over 25% of respondents correctly stated that a vaccinated 80-year-old has a higher risk of dying from COVID-19 than a non-vaccinated 30-year-old. And only 40% knew that vaccinated people were less likely to test positive for coronavirus than those who had not been vaccinated.
The White House will send millions of doses of the vaccine to children as soon as it recovers
In response to an FDA advisory panel supporting the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11, the White House COVID-19 response team said Wednesday that millions of doses would be sent to pediatricians, family doctors, pharmacies, pediatric hospitals and other healthcare agencies. Early inoculation is allowed.
About 28 million children in that age range could become eligible for the Pfizer vaccine early next week.
“We will be ready immediately following the decisions of the FDA and CDC so that parents can vaccinate their children quickly, easily and conveniently,” said Jeff Giants, the team’s coordinator.
Other members of the team highlighted the importance of vaccinating children. Dr. Rochelle Walensky, director of the CDC, said Kovid-195 has become one of the 10 leading causes of death among children aged 5-11, and 8,300 children of that age have been hospitalized with the disease. A recent CDC study found that 42% of American children aged 5-11 were infected with the coronavirus in late June.
Presidential Adviser. Anthony Fawcett said a UK study found that 4.4% of school-age children who had the disease had long-covid, weak and persistent symptoms for at least four weeks.
To answer many of the parents’ questions about the children’s vaccine, click here.
Covid’s instant millionaire. What did they do with the cash?
Pete Vegas had just returned from a vacation with his five grandchildren when he received a strange text saying he had won 1 million. He thought it was a hoax. The Colorado native was a winner of the COVID-19 vaccine lottery in the state of Vegas, which was designed to encourage people to get shots. He plans to use the money to fight climate change.
“My immediate reaction was guilt,” Vegas, 65, said. “My wife and I both said, ‘Wow, we can’t keep this money. We have to do something good with it.’
Several states have funded the vaccine lottery and at least 24 people across the country have claimed the 1 million prize. Here’s what some other vaccine millionaires did with the loot. Read more here.
Infection at the meatpacking plant was 2 1/2 more than believed, the House report says
The number of coronavirus-infected meatpacking workers was 2 1/2 times higher than previously believed, and 269 workers died last year when they were ripped through the Covid-19 industry, according to a new U.S. House report released Wednesday.
The U.S. House Select Subcommittee on Coronavirus Crisis, which used internal documents from the top five meatpacking companies for its report, said companies were slow to take protective measures such as checking workers’ temperatures, providing masks and barricades between work stations.
The report estimates the number of infections at more than 59,000, which is significantly higher than the 22,400 United Food and Commercial Workers. A large percentage of industrial workers are immigrants.
“Instead of dealing with clear indications that workers are being infected with the coronavirus at an alarming rate due to the state of the meatpacking facility, meatpacking companies have prioritized profits and production over worker protection, continuing practices that easily lead to the spread of the virus.” The report said.
In an e-mailed statement to USA Today, UFCW President Mark Peron called on Congress and the US Department of Agriculture to strengthen the safety of meat packing workers.
“Federal regulators were asleep at the switch when the epidemic began and many non-union plant covid workers refused to disclose the full number of infections, leaving many Americans on the frontline vulnerable to the virus,” Peron said.
Louisiana simplifies the ordering of masks as the rate of infection decreases
Louisiana Governor John Bell Edwards has lifted his statewide Covid Mask mandate, excluding schools, which must adhere to recommended quarantine policies before covering their faces. Edwards cited the state’s infection rate and the dramatic drop in hospital admissions for his decision. He also mentioned the possibility of children qualifying for the vaccine within a week, while mourning Louisiana’s lagging vaccination rate as the 45th in the country: “We need to do better.” Individual city and parish government leaders, such as New Orleans Mayor Latoya Cantrell and business owners can still make masks mandatory at their discretion.
“We’ve made tremendous progress and I have no doubt that restoring the masked mandate was the key to it,” Edwards said.
– Greg Hilburn, Lafayette Daily Advertiser
Merck will share the Covid-19 drug formula with the countries in need
US-based pharmaceutical giant Mark has announced a licensing agreement to provide “affordable” global access to its coronavirus drug Malnupiravir. Oral, antiviral drugs are used to treat mild to moderate types of COVID-19 in adults who are at risk of severe COVID-19 and / or hospitalization. The agreement with the Medicine Patent Pool, which works to make medical treatments and technologies globally accessible, will provide access to medicine to 105 low- and middle-income countries.
“Mark’s mission is a truly global commitment to save lives and improve lives,” said Frank Kliburn, president of Mark’s human health department. This agreement with MPP is another important component of our multifaceted strategy to accelerate broad, affordable access to molnupiravir. “
U.S. coronavirus numbers continue to improve
The United States has crossed one important milestone of recovery from the delta variant-driven wave of coronaviruses and is close to another. Data from Johns Hopkins University shows that less than 500,000 cases have been reported in the U.S. since Monday, a number that dropped to 476,873 in the seven-day period ending Tuesday. The country has not been below 500,000 since July 29 and recorded about 1.15 million cases in the week ended September 4.
With nearly two months of reading cases, deaths are also declining and are likely to drop below 10,000 per week soon. There were 10,346 COVID-19 deaths in the seven-day period ending Tuesday, the lowest number since the September 6 holiday, followed by at least 10,000 deaths per week. The death toll from delta-powered waves peaked at 14,648 on September 22, or about 2,100 per day.
– Mike Stuka
The maker of the covacin vaccine is set to begin testing in the United States
Another COVID-19 vaccine maker is hoping to enter the US market, this time a traditional type of shot that has already been distributed more than 100 million times in India.
Ocugen Inc., a publicly traded company based in Malvern, Pennsylvania, announced Wednesday morning that it had submitted an application to the FDA to begin trials of its vaccine, COVAXIN.
The vaccine uses a completely-killed virus, which means it provides an inactivated form of coronavirus in the body. It stimulates a broader immune response than the vaccines currently available in the United States and is more similar to the immune protection provided by a COVID-19 infection, according to Dr. Bruce Forrest, acting chief medical officer at Okujan.
Contributed by: Associated Press